ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
517 hedge funds and large institutions have $26.3B invested in Alexion Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 212 increasing their positions, 190 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
18% less call options, than puts
Call options by funds: $111M | Put options by funds: $135M
20% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 54
Holders
517
Holding in Top 10
16
Calls
$111M
Puts
$135M
Top Buyers
| 1 | +$746M | |
| 2 | +$176M | |
| 3 | +$159M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$157M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$101M |
Top Sellers
| 1 | -$1.26B | |
| 2 | -$161M | |
| 3 | -$145M | |
| 4 |
GE
General Electric
Evendale,
Ohio
|
-$115M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$69.1M |